-
Hepatitis is the medical term for an inflammation of the liver. It is often caused by an infection with certain viruses. Hepatitis B is mainly spread through blood and other body fluids. The risk of becoming infected with this virus is generally very low in Germany and similar countries. more...
-
Overview
(PantherMedia / Rawpixel) Hepatitis is the medical term for an inflammation of the liver. It is often caused by an infection with certain viruses. more...
-
Learn more
Sofosbuvir (Sovaldi) for the treatment of chronic hepatitis C (genotype 2) in adults. In 2014, the Institute for Quality and Efficiency in Health Care (IQWiG, Germany) has examined what advantages and disadvantages the combination of sofosbuvir with peginterferon and/or ribavirin offers in comparison with conventional standard treatments for ... more...
-
Overview
These people develop a permanent (chronic) inflammation of the liver which can cause cirrhosis. The liver then performs increasingly poorly. As long as the effect on liver performance is not noticeable, it is known as “compensated cirrhosis." Signs of advanced (decompensated) cirrhosis include fluid retention in the abdominal cavity, blood clotting problems, and neurological and psychiatric ... more...
-
Overview
These people develop a permanent (chronic) inflammation of the liver which can cause cirrhosis. The liver then gradually loses its ability to work well. The liver then gradually loses its ability to work well. more...
-
Overview
The fixed-dose combination of elbasvir / grazoprevir (trade name: Zepatier) has been approved in Germany since July 2016 for the treatment of chronic hepatitis C in adults (inflammation of the liver caused by hepatitis C viruses). more...
-
Overview
Sofosbuvir (Sovaldi) for the treatment of chronic hepatitis C (genotype 2) in adults Sofosbuvir (Sovaldi) for the first-line treatment of chronic hepatitis C (genotype 2 or 3) in teenagers Sofosbuvir (Sovaldi) for the follow-up treatment of chronic hepatitis C (genotype 2 or 3) in teenagers more...
-
Overview
The fixed-dose combination of glecaprevir / pibrentasvir (trade name: Maviret) has been approved in Germany since July 2017 for the treatment of chronic hepatitis C in adults. more...
-
Overview
Sofosbuvir / velpatasvir / voxilaprevir (Vosevi) for chronic hepatitis C (genotype 2 or 3) without cirrhosis Sofosbuvir / velpatasvir / voxilaprevir (Vosevi) for the treatment of chronic hepatitis C (genotype 3) with compensated cirrhosis more...
-
The human body
Other diseases caused by viruses include influenza, measles or inflammation of the liver (viral hepatitis). Viruses invade healthy cells and start to multiply from these cells. Without these host cells, a virus cannot reproduce. more...
